as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹288.65
Change
-2.0 (-0.69%)
Open
₹287.75
Prev. Close
₹290.65
Day High
₹296.4
Day Low
₹285.2
Volume Analysis
Traded
9,343
Delivered
8,320
Delivery %
89.05%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (3)
- •Low return on equity (0.29%)
- •Below-average fundamentals quality score (49/100)
- •Low operating margin (-4.5%)
Opportunities (1)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹306.16 | ₹301.28 | ₹294.96 | ₹290.08 | ₹283.76 | ₹278.88 | ₹272.56 |
| Fibonacci | ₹301.28 | ₹297.0 | ₹294.36 | ₹290.08 | ₹285.8 | ₹283.16 | ₹278.88 |
| Camarilla | ₹291.73 | ₹290.7 | ₹289.68 | ₹290.08 | ₹287.62 | ₹286.6 | ₹285.57 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
-2.81%
1 Month
-3.8%
3 Months
-6.11%
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹40.91
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
-3.64%
Net margin -1.77% × asset turnover 1.41x × equity multiplier 1.46x
Company Overview
Sector
Healthcare
Market Cap
₹908 Cr
P/E (TTM)
510.0
ROE
0.29%
Book Value
₹201.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Health X Platform Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 49/100. The strongest factor is Financial Strength (100/100), while Business Quality (20/100) is the weakest area to weigh before deciding. Notably: Low return on equity (0.29%); below-average fundamentals quality score (49/100). FII holding has been rising.
TopFund Score — Fundamentals Quality
49/100 — WeakData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is almost debt free.
- +Company is expected to give good quarter
- +Company's median sales growth is 36.1% of last 10 years
- +Company's working capital requirements have reduced from 40.4 days to 16.0 days
- −Company has low interest coverage ratio.
- −Company has a low return on equity of 2.06% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper Publication regarding Notice of 37th Annual General Meeting and e-voting information.
37th AGM scheduled for 28 September 2026; annual report link shared with non-registered shareholders.
Company filed FY2025-26 BRSR and disclosed Rs 8 lakh penalty under Companies Act.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 336 | 358 | 375 | 307 | 270 | 274 | 281 | 286 | 298 | 301 | 346 | 374 | 447 |
| Expenses + | 327 | 355 | 371 | 317 | 273 | 278 | 305 | 311 | 292 | 324 | 356 | 399 | 455 |
| Operating Profit | 9 | 3 | 3 | -11 | -2 | -5 | -24 | -25 | 6 | -23 | -10 | -25 | -8 |
| OPM % | 2.76% | 0.94% | 0.92% | -3.47% | -0.89% | -1.73% | -8.43% | -8.82% | 2.03% | -7.5% | -3.0% | -6.74% | -1.88% |
| Other Income + | 12 | 10 | 20 | 18 | 29 | -167 | -14 | 22 | 25 | 5 | 14 | 13 | 13 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 2 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 19 | 11 | 21 | 5 | 25 | -174 | -39 | -5 | 30 | -19 | 1 | -15 | 2 |
| Tax % | -28.85% | -23.03% | 3.86% | -583.03% | -102.8% | -13.17% | 1.99% | -478.45% | 11.9% | -17.17% | 59.78% | -12.48% | -0.51% |
| Net Profit + | 0 | -12 | -3 | 22 | 41 | -155 | -38 | 18 | 27 | -15 | 0 | -13 | 2 |
| EPS in Rs | 0 | -3 | 0 | 5 | 10 | -34 | -8 | 4 | 8 | -4 | 0 | -4 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,319 | 1,468 |
| Expenses + | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,371 | 1,534 |
| Operating Profit | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -19 | -52 | -67 |
| OPM % | -19.0% | -31.0% | -15.0% | -8.0% | -15.0% | -13.0% | -1.9% | 62.0% | -10.0% | -1.7% | -1.6% | -4.0% | -4.5% |
| Other Income + | 2 | 0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 57 | 45 |
| Interest | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 1 | 1 |
| Depreciation | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 7 | 7 |
| Profit before tax | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | -2 | -31 |
| Tax % | 0.0% | -1.0% | 2.0% | 19.0% | 3.0% | -9.0% | 4.0% | 22.0% | -19.0% | -119.0% | -34.0% | -39.0% | — |
| Net Profit + | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | -1 | -26 |
| EPS in Rs | -5 | -12 | -9 | -4 | -12 | -12 | -3 | 197 | -23 | 3 | -29 | 0 | -6 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 609 |
| Borrowings + | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 26 |
| Other Liabilities + | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 269 |
| Total Liabilities | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 936 |
| Fixed Assets + | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 519 |
| Other Assets + | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 299 |
| Total Assets | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 936 |
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 | -74 |
| Cash from Investing Activity + | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 | 171 |
| Cash from Financing Activity + | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | 0 | -80 |
| Net Cash Flow | -1 | 0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | 0 | -19 | 18 |
| CFO/OP | 106 | 43 | 17 | 377 | 89 | 133 | 288 | -8 | 104 | -172 | 68 | 133 |
| Free Cash Flow | -28 | -18 | 0 | -55 | -33 | -71 | -31 | -212 | -128 | 22 | -27 | -89 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 25.6% | 24.73% | 24.57% | 24.12% | 23.11% | 22.5% | 22.21% | 21.79% | 21.65% | 20.99% | 20.38% | 21.02% |
| Promoters | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.93% | 74.11% | 74.24% | 74.24% | 74.69% | 74.84% | 74.07% |
| FII | 0.32% | 0.49% | 0.56% | 0.61% | 0.99% | 1.71% | 1.6% | 1.88% | 2.04% | 2.25% | 2.17% | 2.29% |
| DII | 0.17% | 0.86% | 0.96% | 1.35% | 1.98% | 1.85% | 2.06% | 2.09% | 2.07% | 2.07% | 2.6% | 2.6% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Health X Platform Limited (this stock) | 908 | 510.0 | 1.42 | 0.29% |
| Shree Ganesh Remedies Ltd | 946 | 61.2 | 5.8 | 10.8% |
| Bafna Pharmaceuticals Ltd | 842 | — | 1.65 | -6.18% |
| Gaudium Ivf N Women H L | 837 | 36.2 | 5.55 | 24.7% |
| Kilitch Drugs India Ltd | 786 | 26.2 | 2.81 | 10.6% |
| Wanbury Limited | 784 | 18.2 | 12.38 | 76.5% |
| Zim Laboratories Limited | 743 | 201.0 | 2.49 | 1.59% |
Which Mutual Funds Hold Health X Platform Limited?
Frequently Asked Questions about Health X Platform Limited
Health X Platform Limited (HEALTHX) closed at ₹288.65 on NSE on 25 September 2026, down 2.0 (0.69%) from the previous close.
Health X Platform Limited trades on the NSE (National Stock Exchange of India) under the symbol HEALTHX.
Health X Platform Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 510.0.
Health X Platform Limited has a dividend yield of 0.0%.
Health X Platform Limited's 52-week high is ₹375.0 and its 52-week low is ₹252.0.
Health X Platform Limited has a market capitalisation of ₹908 crore.
Health X Platform Limited has a TopFund Quality Score of 49/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Health X Platform Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.